• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/26

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

26 Cards in this Set

  • Front
  • Back
whole blood MOA
increases circulating blood volume
whole blood uses
replacement therapy for acute blood loss secondary to traumatic injuries or surgical procedures

volume expansion in clients who have extensive burn injury, dehydration, and shock
whole blood adverse
circulatory overload along with common side effects of these
PRBCS MOA
increase the number of RBCs
PRBCs use
severe symptomatic anemia
hemoglobinopathies
medication induced hemolytic anemia
erythroblastosis fetalis
PRBCs adverse
common effects
Blood and blood products common adverse
acute hemolytic reaction
febrile nonhemolytic reaction
anaphylactic reaction
mild allergic reaction
hyperkalemia
transfusion associated graft versus host disease
sepsis
platelet concentrate MOA
increases platelet counts
platelet concentrate USe
thrombocytopenia (platelet count less than 20000
aplastic anemia
chemotherapy induced bone marrow suppression
active bleeding platelet count
platelet adverse
febrile nonhemolytic reaction
mild allergic reactions
sepsis
fresh frozen plasma MOA
replaces coagulation factors
fresh frozen plasma use
active bleeding or massive hemorrhage
extensive burns
shock
disseminated intravascular coagulation
fresh frozen plasma adverse
common effects of blood and blood products
pheresed granulocytes
replaces neutorphils/granulocytes
pheresed granulocytes use
severe neutropenia (ANC less than 500)
life-theatening bacterial/fungal infection not responding to antibiotic therapy.
neonatal sepsis
neutrophil dysfunction
pheresed granulocytes adverse
common effects of blood and blood products
albumin MOA
expands circulating blood volume by exerting oncotic pressure
albumin use
hypovolemia
hypoalbuminemia
burns
adult respiratory disease
cardiopulmonary bypass surgery
hemolytic disease of the newborn
albumin adverse
risk for fluid volume excess such as pulmonary edema
blood and blood products interventions
acute hemolytic reaction usually occurs during the first 50 mL of infusion but onset may be delayed
if manifestations occur, stop infusion immediately keeping IV line open with 0.9 sodium chloride and new IV tubing (Iv line open for febrile nonhemolytic reaction, anaphylactic reactions, mild allergic reactions)
circulatory overload: wait 2 hours between blood units
if clinical manifestations occur, stop transfusion and notify provider immediately
place client upright with feet down
administer diuretics and oxygen as appropriate
monitor I and O
prior to any transfusion, assess kidney, respiratory, and cardiovascular for risk of overload
sepsis- transfuse unit of blood within 2-4 hours after being removed from refrigerator
obtain blood culture, send transfusion bag or analysis for possible contaminants and treat sepsis with antibiotics, IV fluids, vasopressors, steroids

be aware that lysis is more likely in producs that were previously frozen or older than one week
blood and blood products contraindications
hypersensitivity reactions
whole blood, PRBCs transfusion time
whole blood, PRBCs,- 250 mL/unit; infuse within 2-4 hours
platelet concentrate transfusion time
300 mL/unit infuse PRBCs within 15-30 min
fresh frozen plasma
200 mL/ unit infuse within 30- 60 min
albumin
5% 250-500 mL infuse 1 to 10 mL/min
25% 50-100 mL bottle infuse 4 mL/min
administration blood products
pg. 354